BD Phoenix™ NMIC/ID-307 449289Recalls & reported problems
Becton, Dickinson And Company · BD Phoenix™ NMIC/ID-307 · Class 2
Quick summary
This BD Phoenix bacteria identification panel has 524 adverse event reports, with no deaths and no injuries. Almost all describe incorrect results, mainly bacteria being identified as the wrong species. Reports fell from 221 in the prior 12 months to 22 in the last 12 months. No recalls name this device.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 529
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 529 adverse event reports that list this exact device (DI 30382904492893), received between Mar 25, 2021 and Sep 3, 2026 — classified as 529 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (524 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings524
- False Positive Result3
- Device Markings/Labelling Problem1
- False Negative Result1
Patient problems
- No Clinical Signs, Symptoms or Conditions527
- Insufficient Information2
Recent adverse event reports
The 25 most recent of 529 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 3, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50588370 ↗MalfunctionSep 2, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50569354 ↗MalfunctionAug 11, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50213122 ↗MalfunctionAug 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50165357 ↗MalfunctionAug 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50165356 ↗MalfunctionAug 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50161556 ↗MalfunctionAug 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50156428 ↗MalfunctionAug 6, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50156381 ↗MalfunctionMay 19, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED. THE USER SPECIFIED ORGANISMS CITROBACTER BRAAKII AND CITROBACTER FREUNDII WERE IDENTIFIED WITH EACH REPEAT OF THE ISOLATE. THE USER REPORTED CITROBACTER SPP. TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25218564 ↗MalfunctionMay 19, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED. THE USER SPECIFIED ORGANISMS CITROBACTER BRAAKII AND CITROBACTER FREUNDII WERE IDENTIFIED WITH EACH REPEAT OF THE ISOLATE. THE USER REPORTED CITROBACTER SPP. TO PROVIDERS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25217910 ↗MalfunctionMay 8, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE (CITROBACTER SPP.) WAS MISIDENTIFIED AS ESCHERICHIA COLI. THE USER VERIFIED THE FINAL RESULT USING MALDI.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25128942 ↗MalfunctionMay 5, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE (ESCHERICHIA COLI) WAS MISIDENTIFIED AS ENTEROBACTER CLOACAE. THE USER VERIFIED THE FINAL RESULT USING MALDI.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25085981 ↗MalfunctionApr 3, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE (PROTEUS MIRABILIS) WAS MISIDENTIFIED AS ESCHERICHIA COLI. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24778225 ↗MalfunctionApr 3, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE (PROTEUS MIRABILIS) WAS MISIDENTIFIED AS ESCHERICHIA COLI. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24775763 ↗MalfunctionMar 19, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE FROM A URINE CULTURE (ESCHERICHIA COLI) HAD HIGH MICS FOR THE CARBAPENEM DRUG CLASS, THE USER ALSO NOTED PERFORMING REPEAT TESTING. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER IS UNSURE OF PATIENT IMPACT. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24638624 ↗MalfunctionMar 19, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE FROM A URINE CULTURE (ESCHERICHIA COLI) HAD HIGH MICS FOR THE CARBAPENEM DRUG CLASS, THE USER ALSO NOTED PERFORMING REPEAT TESTING. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER IS UNSURE OF PATIENT IMPACT. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24638620 ↗MalfunctionMar 19, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE (ESCHERICHIA COLI) HAD HIGH MICS FOR THE CARBAPENEM DRUG CLASS. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER IS UNSURE IF PATIENT TREATMENT WAS AFFECTED. THIS IS REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24638619 ↗MalfunctionFeb 17, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24364107 ↗MalfunctionFeb 17, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 3 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24364106 ↗MalfunctionFeb 17, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 3 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24364104 ↗MalfunctionFeb 17, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 2 OF 3.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24364103 ↗MalfunctionFeb 16, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24349557 ↗MalfunctionFeb 16, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC/ID-307 A PATIENT ISOLATE WAS MISIDENTIFIED AS SHIGELLA BOYDII. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER STATED, "SHIGELLA BOYDII WAS REPORTED AND SEEN BY THE DOCTOR. A REFERENCE LAB THAT THE ISOLATE WAS SENT TO, SENT BACK A RESULT OF "SHIGELLA NOT FOUND." THE CUSTOMER SUSPECTS THAT THE PATIENT WAS TREATED BUT DOES NOT HAVE DETAILS. ALL ANTIBIOTICS FOR THE ISOLATE WERE SENSITIVE." NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24349553 ↗MalfunctionDec 17, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES (ESCHERICHIA COLI) HAD A HIGH MIC (FALSE RESISTANT) RESULT FOR THE DRUG ERTAPENEM. THE USER VERIFIED THE FINAL RESULT USING E-TEST STRIP. THE USER ALSO NOTED THE FAILURE FOR QC RESULTS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23830480 ↗MalfunctionNov 20, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE PANEL PHOENIX NMIC/ID-307 A PATIENT ISOLATE FROM A URINE CULTURE (ESCHERICHIA COLI) HAD HIGH MICS FOR THE CARBAPENEM DRUG CLASS, THE USER ALSO NOTED PERFORMING REPEAT TESTING. THE USER VERIFIED THE FINAL RESULT USING A REFERENCE LABORATORY. THE USER IS UNSURE OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23609704 ↗
Other SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION devices
- BD Phoenix™ M50 Automated Microbiology System 443624Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION3 recalls417 reports
- BD Phoenix™ PMIC/ID-107 448607Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION2 recalls169 reports
- BD Phoenix™ NMIC-306 449292Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION1 recall143 reports
- VITEK® 2 AST-GP67Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls83 reports
- BD Phoenix™ AST Broth 246003Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION182 reports
- VITEK® 2 AST-GP75Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls52 reports
- VITEK® 2 AST-GP78Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls41 reports
- VITEK® 2 AST-GN95Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls2 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.